{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:58:25Z","timestamp":1787626705456,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejmech.2020.112470","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T11:50:31Z","timestamp":1589802631000},"page":"112470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction"],"prefix":"10.1016","volume":"200","author":[{"given":"Xiang","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Biao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Zhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112470_bib1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1846706","article-title":"Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product","volume":"251","author":"Bottaro","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112470_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/318385a0","article-title":"The human met oncogene is related to the tyrosine kinase oncogenes","volume":"318","author":"Dean","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112470_bib3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2020.112470_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopha.2017.12.045","article-title":"Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met\/PI3K\/Akt signaling pathway","volume":"98","author":"Gao","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2020.112470_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1432-1327.1999.00507.x","article-title":"Deregulation of the signaling pathways controlling urokinase production","volume":"263","author":"Aguirre Ghiso","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2020.112470_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ejmech.2017.08.044","article-title":"Recent advances in the discovery of small molecule c-Met Kinase inhibitors","volume":"143","author":"Parikh","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib7","doi-asserted-by":"crossref","first-page":"13976","DOI":"10.1039\/C8RA00522B","article-title":"Celastrol delays hepatic steatosis and carcinogenesis in a rapid AKT\/c-Met-transfected hepatocellular carcinoma model via suppressing fatty acid synthase expression and AKT\/ERK phosphorylation","volume":"8","author":"Hu","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112470_bib8","first-page":"853","article-title":"Autocrine hepatocyte growth factor\/scatter factor-Met signaling induces transformation and the invasive\/metastastic phenotype in C127 cells","volume":"13","author":"Jeffers","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2020.112470_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1073\/pnas.94.2.701","article-title":"Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor\/scatter\u2009factor","volume":"94","author":"Takayama","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2020.112470_bib10","first-page":"5157","article-title":"c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype","volume":"58","author":"Otsuka","year":"1998","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112470_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lungcan.2018.09.008","article-title":"MET amplification increases the metastatic spread of EGFR-mutated NSCLC","volume":"125","author":"Baldacci","year":"2018","journal-title":"Lung Canc."},{"key":"10.1016\/j.ejmech.2020.112470_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2019.04.028","article-title":"c-MET as a biomarker in patients with surgically resected non-small cell lung cancer","volume":"133","author":"Tsakonas","year":"2019","journal-title":"Lung Canc."},{"key":"10.1016\/j.ejmech.2020.112470_bib13","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/ijc.24554","article-title":"Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients","volume":"125","author":"Toiyama","year":"2009","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2020.112470_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.09.044","article-title":"c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention","volume":"225","author":"Christensen","year":"2005","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2020.112470_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.canlet.2018.03.045","article-title":"Recruited T cells promote the bladder cancer metastasis via upregulation of the estrogen receptor \u03b2\/IL-1\/c-MET signals","volume":"430","author":"Tao","year":"2018","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2020.112470_bib16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.2008.19.1635","article-title":"Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients","volume":"27","author":"Cappuzzo","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2020.112470_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5604\/01.3001.0011.7395","article-title":"Therapeutic effect of HGF on NASH mice through HGF\/c-Met and JAK2-STAT3 signalling pathway","volume":"17","author":"Li","year":"2018","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ejmech.2020.112470_bib18","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1073\/pnas.131200498","article-title":"Neutralizing monoclonal antibodies to hepatocyte growth factor\/scatter factor (HGF\/SF) display antitumor activity in animal models","volume":"98","author":"Cao","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2020.112470_bib19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1158\/1078-0432.CCR-05-1793","article-title":"Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts","volume":"12","author":"Kim","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112470_bib20","first-page":"7518","article-title":"Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model","volume":"61","author":"Tomioka","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112470_bib21","first-page":"4578","article-title":"Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor\/hepatocyte growth factor-antagonist NK4","volume":"9","author":"Brockmann","year":"2003","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112470_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ccr.2004.05.032","article-title":"Targeting the tumor and its microenvironment by a dual-function decoy Met receptor","volume":"6","author":"Michieli","year":"2004","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2020.112470_bib23","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/jnci\/91.18.1548","article-title":"Reversion of human glioblastoma malignancy by U1 small nuclear RNA\/ribozyme targeting of scatter factor\/hepatocyte growth gactor and c-Met expression","volume":"91","author":"Abounader","year":"1999","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2020.112470_bib24","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1039\/C8LC00330K","article-title":"Applications of tumor chip technology","volume":"18","author":"Hachey","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.ejmech.2020.112470_bib25","doi-asserted-by":"crossref","first-page":"22376","DOI":"10.1039\/C9RA01785B","article-title":"RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells via the posttranscriptional suppression of HGFR","volume":"9","author":"Shi","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112470_bib26","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1158\/0008-5472.CAN-07-5960","article-title":"MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival","volume":"68","author":"Jin","year":"2008","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112470_bib27","first-page":"221","article-title":"From concept to reality: the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer, Anti-cancer Agents","volume":"9","author":"Dussault","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2017.12.078","article-title":"Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors","volume":"145","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejmech.2019.06.033","article-title":"2,7-Naphthyridinone-based MET kinase inhibitors: a promising novel scaffold for antitumor drug development","volume":"178","author":"Zhuo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib30","doi-asserted-by":"crossref","first-page":"112244","DOI":"10.1016\/j.ejmech.2020.112244","article-title":"Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors","volume":"194","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.critrevonc.2018.08.007","article-title":"c-Met as a potential target therapy toward personalized therapy in some pediatric tumors: an overview","volume":"131","author":"Rashed","year":"2018","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.ejmech.2020.112470_bib32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.bmc.2016.02.003","article-title":"Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors","volume":"24","author":"Zhai","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2017.11.073","article-title":"Discovery, optimization and biological evaluation for novel c-Met kinase inhibitors","volume":"143","author":"Yuan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib34","doi-asserted-by":"crossref","first-page":"112241","DOI":"10.1016\/j.ejmech.2020.112241","article-title":"Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions","volume":"193","author":"Nan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib35","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1016\/j.bmc.2013.10.028","article-title":"Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors","volume":"21","author":"Matsumoto","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib36","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1021\/jm2007613","article-title":"Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)","volume":"54","author":"Cui","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2016.04.035","article-title":"Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors","volume":"119","author":"Liu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejmech.2018.11.057","article-title":"Discovery of N1-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)-N3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl) urea as a multi-tyrosine kinase inhibitor for drug-sensitive and drug-resistant cancers treatment","volume":"163","author":"Qi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbrc.2018.05.034","article-title":"Met receptor inhibitor SU11274 localizes in the endoplasmic reticulum","volume":"501","author":"Wiest","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2020.112470_bib40","first-page":"7","article-title":"Discovery of small molecule c-Met inhibitors: evolution and profiles of clinical candidates, Anti-Cancer Agents","volume":"10","author":"Underiner","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2016.07.059","article-title":"Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors","volume":"123","author":"Liu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib42","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1021\/jm8006189","article-title":"Design, synthesis, and biological evaluation of potent c-Met inhibitors","volume":"51","author":"D\u2019Angelo","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejmech.2016.04.062","article-title":"Synthesis and biological evaluation of 4-(2-fluorophenoxy)-3,3\u2032-bipyridine derivatives as potential c-met inhibitors","volume":"120","author":"Zhao","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib44","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/jm201331s","article-title":"Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series","volume":"55","author":"Liu","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib45","doi-asserted-by":"crossref","first-page":"29714","DOI":"10.1039\/C8RA04879G","article-title":"Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives","volume":"8","author":"Younas","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112470_bib46","doi-asserted-by":"crossref","first-page":"115018","DOI":"10.1016\/j.taap.2020.115018","article-title":"The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies","volume":"398","author":"Shakera","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112470_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejmech.2018.08.066","article-title":"Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety","volume":"158","author":"Tang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib48","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.bmc.2015.06.026","article-title":"Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors","volume":"23","author":"Liao","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1081","article-title":"Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules","volume":"1","author":"Galloway","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.112470_bib50","doi-asserted-by":"crossref","first-page":"102916","DOI":"10.1016\/j.bioorg.2019.04.010","article-title":"Synthesis and anti-tumor activity of [1,4]dioxino [2,3-f]quinazoline derivatives as dual inhibitors of c-Met and VEGFR-2","volume":"88","author":"Wei","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/anie.200703073","article-title":"Towards the optimal screening collection: a synthesis strategy","volume":"47","author":"Nielsen","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112470_bib52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1039\/b706296f","article-title":"Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries","volume":"25","author":"Cordier","year":"2008","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2020.112470_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0079-6468(08)70378-3","article-title":"Amidines and guanidines in medicinal chemistry","volume":"30","author":"Greenhill","year":"1993","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib54","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1039\/c1cs15236j","article-title":"Transition metal-catalyzed N-arylations of amidines and guanidines","volume":"41","author":"Rauws","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2020.112470_bib55","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.ejmech.2007.10.005","article-title":"Synthesis of biologically active N-methyl derivatives of amidines and cyclized five-membered products of amidines with oxalyl chloride","volume":"43","author":"Sondhi","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1568009023334060","article-title":"Sulfonamides and sulfonylated derivatives as anticancer agents","volume":"2","author":"Casini","year":"2002","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2020.112470_bib57","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.bmc.2011.02.010","article-title":"Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1","volume":"19","author":"Nishino","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib58","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/anie.200705940","article-title":"Room temperature copper-catalyzed 2-functionalization of pyrrole rings by a three-component coupling reaction","volume":"47","author":"Cho","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112470_bib59","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1002\/anie.201004685","article-title":"Three-component assembly and divergent ring-expansion cascades of functionalized 2-iminooxetanes","volume":"49","author":"Yao","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112470_bib60","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1021\/ja0432968","article-title":"Highly efficient one-pot synthesis of N-sulfonylamidines by Cu-catalyzed three-component coupling of sulfonyl azide, alkyne, and amine","volume":"127","author":"Bae","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112470_bib61","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1021\/jm5003588","article-title":"Design, synthesis, mechanisms of action, and toxicity of novel 20(S)-sulfonylamidine derivatives of camptothecin as potent antitumor agents","volume":"57","author":"Wang","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejmech.2017.06.008","article-title":"Thiophene\/thiazole-benzene replacement on guanidine derivatives targeting \u03b12-adrenoceptors","volume":"138","author":"Flood","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1039\/B9NJ00474B","article-title":"Cyclisation reactions of some pyridazinylimidoylketenes","volume":"34","author":"Gaywood","year":"2010","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bmcl.2003.10.030","article-title":"Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity","volume":"14","author":"Munchhof","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112470_bib65","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2019.01.065","article-title":"Quinolone antibiotic derivatives as new selective Axl kinase inhibitors","volume":"166","author":"Tan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejmech.2017.11.016","article-title":"Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands","volume":"147","author":"Sun","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib67","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1055\/s-0033-1338743","article-title":"Convenient and environment-friendly synthesis of sulfonyl chlorides from S-alkylisothiourea salts via N-chlorosuccinimide chlorosulfonation","volume":"45","author":"Yang","year":"2013","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2020.112470_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejmech.2016.02.070","article-title":"Design, synthesis, cytotoxic activity and molecular docking studies of new 20(S)-sulfonylamidine camptothecin derivatives","volume":"115","author":"Song","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib69","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1021\/jf501108j","article-title":"Design, synthesis, crystal structure, insecticidal activity, molecular docking, and QSAR studies of novel N3-substituted imidacloprid derivatives","volume":"62","author":"Wang","year":"2014","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib70","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.bmc.2019.05.007","article-title":"Design, synthesis and evaluation of sulfonylurea-containing 4-phenoxyquinolines as highly selective c-Met kinase inhibitors","volume":"27","author":"Nan","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib71","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/jm800791f","article-title":"Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening","volume":"52","author":"Peach","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib72","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1021\/jm800476q","article-title":"Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities","volume":"51","author":"Kim","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112470_bib73","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:17:05Z","timestamp":1759328225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420304414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":73,"alternative-id":["S0223523420304414"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112470","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112470"}}